Double radiation attack on resistant prostate cancer enters human testing
NCT ID NCT04886986
First seen Apr 10, 2026 · Last updated Jun 15, 2026 · Updated 12 times
Summary
This early-phase study tests a new combination of two drugs that deliver radiation directly to prostate cancer cells. The goal is to find the safest dose that can be given together. About 42 men with advanced prostate cancer that has stopped responding to hormone therapy will take part. The study focuses on safety and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brooklyn Methodist Hospital - New York Presbyterian
RECRUITINGBrooklyn, New York, 11215, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Weill Cornell Medicine New York Presbyterian
RECRUITINGNew York, New York, 10065, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.